Company news

Revvity, Inc. news in 2026

Revvity, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Revvity Announces Financial Results for the Third Quarter of 2026

November 3, 2026

Revvity Board Declares Quarterly Dividend

October 30, 2026

Revvity Launches Signals LabGistics Solution to Connect and Orchestrate Scientific Workflows

October 20, 2026

Revvity to Present at Upcoming Investor Conferences

October 13, 2026

Revvity to Hold Earnings Call on November 3, 2026

October 2, 2026

Revvity Launches IVDR-Certified Solution for Early Detection of Type 1 Diabetes

September 24, 2026

Revvity to Acquire Human Cell Design to Advance Human-Relevant Cell Models for Metabolic Disease Drug Discovery

September 9, 2026

Quarterly Report for Quarter Ending July 5, 2026 (Form 10-Q)

August 11, 2026

Revvity Announces Financial Results for the Second Quarter of 2026

August 4, 2026

Revvity Releases 2026 Impact Report Advancing Transparency with Initial Scope 3 Emissions Disclosure

July 20, 2026

Revvity to Hold Earnings Call on Tuesday, August 4, 2026

July 8, 2026

Revvity Expands Signals AI Ecosystem Through Anthropic Claude Integration

July 1, 2026

Revvity Launches Signals AI, a Native Agentic Framework for Accelerating Scientific R&D

June 22, 2026

Revvity Announces Financial Results for the First Quarter of 2026

May 5, 2026

Revvity Showcases Integrated Cancer Research Solutions at AACR Annual Meeting 2026

April 16, 2026

Revvity to Hold Earnings Call on Tuesday, May 5, 2026

April 10, 2026

Revvity Unveils its Signals BioDesign Offering to Advance Biologic Research Workflows

April 9, 2026

Annual Report for Fiscal Year Ending 12/28, 2025 (Form 10-K)

February 24, 2026

Revvity Unveils New High-Impact Discovery Platforms and Showcases Recent Innovations at SLAS2026

February 5, 2026

Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2025

February 2, 2026

Revvity Board Declares Quarterly Dividend

January 26, 2026

Revvity to Hold Earnings Call on Monday, February 2, 2026; Provides Update on Financial Performance

January 12, 2026

Revvity Collaborates with Lilly to Expand Access to AI Drug Discovery Models

January 9, 2026

Calls in 2026

Decks in 2026